PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 1982 June; 69(6): 1302–1309.
PMCID: PMC370203

Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.

Abstract

In 100 patients with various types of endocrine dysfunction, we measured bone mineral density (BMD) at the midradius (greater than 95% cortical bone) and distal radius (75% cortical and 25% trabecular bone) by single photon absorptiometry and at the lumbar spine (greater than 66% trabecular bone) using the new technique of dual photon absorptiometry. BMD in each endocrine disorder deviated in at least one site from the sex-specific age regression of 187 normal subjects. For patients with primary hyperparathyroidism, hypercortisolism, and hyperthyroidism this deviation was negative (suggesting bone loss), whereas for patients with secondary hyperparathyroidism due to chronic renal failure, acromegaly, and postsurgical hypoparathyroidism it was positive (suggesting bone gain). When all six states of endocrine dysfunction were compared concomitantly by multivariate analysis of variance, the profile of the changes in BMD differed significantly (P less than 0.001), indicating a nonuniform response of bone to the various hormonal alterations. When values for BMD at each of the three scanning sites were compared the midradius and distal radius did not differ significantly; either of the radius measurements, however, differed significantly (P less than 0.001) from the lumbar spine. Thus, the BMD of the axial skeleton cannot be reliably predicted from measurements made in the appendicular skeleton. We conclude that the effects of endocrine dysfunction on bone density are complex and are both disease and site specific.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • GONG JK, ARNOLD JS, COHN SH. COMPOSITION OF TRABECULAR AND CORTICAL BONE. Anat Rec. 1964 Jul;149:325–331. [PubMed]
  • ROWLAND RE, MARSHALL JH. Radium in human bone: the dose in microscopic volumes of bone. Radiat Res. 1959 Sep;11:299–313. [PubMed]
  • Frost HM. Treatment of osteoporoses by manipulation of coherent bone cell populations. Clin Orthop Relat Res. 1979 Sep;(143):227–244. [PubMed]
  • Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ., 3rd Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest. 1981 Feb;67(2):328–335. [PMC free article] [PubMed]
  • CAMERON JR, SORENSON J. MEASUREMENT OF BONE MINERAL IN VIVO: AN IMPROVED METHOD. Science. 1963 Oct 11;142(3589):230–232. [PubMed]
  • Wahner HW, Riggs BL, Beabout JW. Diagnosis of osteoporosis: usefulness of photon absorptiometry at the radius. J Nucl Med. 1977 May;18(5):432–437. [PubMed]
  • Dunn WL, Wahner HW, Riggs BL. Measurement of bone mineral content in human vertebrae and hip by dual photon absorptiometry. Radiology. 1980 Aug;136(2):485–487. [PubMed]
  • Pak CY, Stewart A, Kaplan R, Bone H, Notz C, Browne R. Photon absorptiometric analysis of bone density in primary hyperparathyroidism. Lancet. 1975 Jul 5;2(7923):7–8. [PubMed]
  • Hahn TJ, Boisseau VC, Avioli LV. Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass. J Clin Endocrinol Metab. 1974 Aug;39(2):274–282. [PubMed]
  • Dalén N, Hjern B. Bone mineral content in patients with primary hyperparathyroidism without radiological evidence of skeletal changes. Acta Endocrinol (Copenh) 1974 Feb;75(2):297–304. [PubMed]
  • Parfitt AM. Metacarpal cortical dimensions in hypoparathyroidism, primary hyperparathyroidism and chronic renal failure. Calcif Tissue Res. 1977 May;22 (Suppl):329–331. [PubMed]
  • Hossain M, Smith DA, Nordin BE. Parathyroid activity and postmenopausal osteoporosis. Lancet. 1970 Apr 18;1(7651):809–811. [PubMed]
  • Dauphine RT, Riggs BL, Scholz DA. Back pain and vertebral crush fractures: an unemphasized mode of presentation for primary hyperparathyroidism. Ann Intern Med. 1975 Sep;83(3):365–367. [PubMed]
  • Genant HK, Baron JM, Straus FH, Paloyan E, Jowsey J. Osteosclerosis in primary hyperparathyroidism. Am J Med. 1975 Jul;59(1):104–113. [PubMed]
  • Campos C, Arata RO, Mautalen CA. Parathyroid hormone and vertebral osteosclerosis in uremic patients. Metabolism. 1976 May;25(5):495–501. [PubMed]
  • Doyle FH. Some quantitative radiological observations in primary and secondary hyperparathyroidism. Br J Radiol. 1966 Mar;39(459):161–167. [PubMed]
  • Doyle FH. Radiology of the skeleton in endocrine diseases. Proc R Soc Med. 1967 Nov 1;60(11 Pt 1):1131–1132. [PMC free article] [PubMed]
  • Koutras DA, Pandos PG, Koukoulommati AS, Constantes J. Radiological signs of bone loss in hyperthyroidism. Br J Radiol. 1973 Sep;46(549):695–698. [PubMed]
  • Fraser SA, Anderson JB, Smith DA, Wilson GM. Osteoporosis and fractures following thyrotoxicosis. Lancet. 1971 May 15;1(7707):981–983. [PubMed]
  • Riggs BL, Randall RV, Wahner HW, Jowsey J, Kelly PJ, Singh M. The nature of the metabolic bone disorder in acromegaly. J Clin Endocrinol Metab. 1972 Jun;34(6):911–918. [PubMed]
  • Aloia JF, Zanzi I, Ellis K, Jowsey J, Roginsky M, Wallach S, Cohn SH. Effects of growth hormone in osteoporosis. J Clin Endocrinol Metab. 1976 Nov;43(5):992–999. [PubMed]
  • Nordin BE, Horsman A, Crilly RG, Marshall DH, Simpson M. Treatment of spinal osteoporosis in postmenopausal women. Br Med J. 1980 Feb 16;280(6212):451–454. [PMC free article] [PubMed]
  • Bekier A. Der Nachweis der "thyreogenen Osteopathie" mit Hilfe moderner Photonenabsorptionstechnik. Schweiz Med Wochenschr. 1975 Mar 8;105(10):304–307. [PubMed]
  • Bordier P, Miravet L, Matrajt H, Hioco D, Ryckewaert A. Bone changes in adult patients with abnormal thyroid function (with special reference to 45Ca kinetics and quantitative histology). Proc R Soc Med. 1967 Nov 1;60(11 Pt 1):1132–1134. [PMC free article] [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation